TD Cowen Reiterates Buy on DexCom, Maintains $95 Price Target

TD Cowen analyst Joshua Jennings has reiterated a 'Buy' rating on DexCom (NASDAQ: DXCM) and maintained a price target of $95 for the stock. This endorsement suggests continued confidence in the company's performance and potential for growth.